|
| Exchange Disseminated Time | Marksans Pharma Ltd has informed BSE that the members at the 18th Annual General Meeting (AGM) of the Company held on September 28, 2010, inter alia, have passed the following resolutions:
1. Adoption of the Audited Balance Sheet as at March 31, 2010 & the Profit and Loss Account for the period ended March 31, 2010 and the Reports of the Directors and the Auditors’ thereon together with all annexures and schedules mentioned therein.
2. Appointment of Mr. Kumar Nair as a Director of the Company liable to retire by rotation.
3. Appointment of M/s. N. K. Mittal, Chartered Accountants as the Auditors of the Company to hold the office from the Conclusion of this Annual General Meeting till Conclusion of the Next Annual General Meeting on remuneration terms & Conditions.
4. Appointment of Mr. Mark Saldanha as the Managing Director of the Company, not liable to retire by rotation, for a period of 5 (five) years with effect from October 06, 2010, on remuneration, terms & conditions. |
|
|